← Eichor
Study identifier: NCT03701581 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

4-aminopyridine Treatment for Nerve Injury

Condition: Nerve Injury · Prostate Cancer  ·  Sponsor: John Elfar

PhasePhase 2/Phase 3
Planned participants70
Who can joinMale, 45 Years to 75 Years
Healthy volunteersNo

About this study

To evaluate the role of 4-aminopyridine (4-AP) on the course of recovery after peripheral nerve traction and/or crush injury. This study aims to test the hypothesis that 4-aminopyridine speeds the often slow and unpredictable recovery after peripheral nerve traction and/or crush injuries.

This description comes directly from the study's public registry record.

Talk to the study team

Andrea Horne  ·  520-626-6456  ·  ahh@arizona.edu

Always discuss trial participation with your own doctor first.

Locations (2)

University of ArizonaTucson, Arizona, United StatesRecruiting
University of RochesterRochester, New York, United StatesTerminated

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03701581